Physician profile
Scott D Moon
NPI 1366415309
$1,519.04
in general payments reported to CMS, 2019-2025
16 companies · $205 in 2025
The $205 reported for 2025 was more than what a typical Radiation Oncology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $124 · 2022: $205 · 2023: $545 · 2024: $439 · 2025: $205.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,190.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,189.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $251.70 | 2023 | Orgovyx |
| Janssen Biotech, INC. | $249.11 | 2022-2025 | Rybrevant, Erleada, Darzalex |
| Pfizer INC. | $213.49 | 2022-2024 | |
| Astrazeneca Pharmaceuticals LP | $177.77 | 2023-2024 | Imfinzi |
| E.R. Squibb & Sons, L.L.C. | $158.50 | 2019-2023 | Opdivo |
| Regeneron Healthcare Solutions, INC. | $125.00 | 2024 | Libtayo |
| Novartis Pharmaceuticals Corporation | $110.37 | 2025 | |
| Astellas Pharma US INC | $51.07 | 2022-2023 | Xtandi |
| Siemens Medical Solutions USA, INC. | $28.37 | 2022 | |
| Ipsen Biopharmaceuticals, INC | $27.07 | 2023 | Somatuline Depot, Onivyde |
| Eisai INC. | $25.91 | 2023 | |
| Reflexion Medical, INC. | $25.00 | 2025 | Reflexion Medical Radiotherapy System |
| Coherus Oncology, INC. | $24.21 | 2025 | Loqtorzi |
| Amgen INC. | $23.65 | 2022 | |
| Genzyme Corporation | $14.52 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $13.30 | 2024 | Keytruda |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Moon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.